"O IBPClin um Centro de Pesquisa Clínica, dedicado à condução de grandes estudos multicêntricos para desenvolvimento de novos medicamentos para a indústria farmacêutica."

During the past decade, IBPClin - Instituto Brasil de Pesquisa Clínica conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 4 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IBPClin - Instituto Brasil de Pesquisa Clínica" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Pfizer" with 4 trials sponsored, "Amgen" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Anji Pharma" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IBPClin - Instituto Brasil de Pesquisa Clínica" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "IBPClin - Instituto Brasil de Pesquisa Clínica" are "Obesity" (5 trials), "Overweight" (4 trials), "COVID-19" (2 trials), "Crohn Disease" (2 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "IBPClin - Instituto Brasil de Pesquisa Clínica" in a lesser frequency.

Most popular intervention types in "IBPClin - Instituto Brasil de Pesquisa Clínica" are "Drug" (19 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Tirzepatide" (7 trials), "Baricitinib" (2 trials), "Etrolizumab" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "IBPClin - Instituto Brasil de Pesquisa Clínica" are 21 trials for "All" genders.

Currently, there are NaN active trials in "IBPClin - Instituto Brasil de Pesquisa Clínica". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in IBPClin - Instituto Brasil de Pesquisa Clínica, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in IBPClin - Instituto Brasil de Pesquisa Clínica, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".